Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices
February 06, 2024 at 06:56 AM EST
The quarterly results are the first to include sales of Eli Lilly's new weight loss drug Zepbound, which won FDA approval in early November.
